Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
How do new studies assess lipitor's impact on overall liver health?Rybelsus diabetes drug market position?Generic januvia release date?Metformin hydrochloride patent expiry date half life therapeutic area?Januvia sitagliptin 100 mg price?
See the DrugPatentWatch profile for breo
Breo Ellipta is a brand-name inhaler containing two medicines: fluticasone furoate (an inhaled corticosteroid) and vilanterol (a long-acting beta agonist, LABA). The generic equivalent is typically sold as a combination inhaler of fluticasone furoate and vilanterol under its generic name. [1]
Breo Ellipta is not a single drug; it is a fixed-dose combination (fluticasone furoate + vilanterol). Generic products for this kind of inhaler are normally approved as the same combination at the same strengths and dosing instructions, even though they may come in a different brand name. [1]
Ask the pharmacist for the inhaler whose active ingredients are fluticasone furoate and vilanterol (same dose/strength as your current Breo Ellipta). That’s the practical way to match the generic to the exact product you use. [1]
Check that the product matches your Breo Ellipta strength (commonly prescribed as 100/25 mcg or 200/25 mcg of fluticasone furoate/vilanterol) and that the device is the equivalent type for that prescription. [1] Sources: [1] https://www.drugpatentwatch.com/
Other Questions About Breo :